||Kevin C. Kain, MD, FRCPC
Professor of Medicine, University of Toronto.
Director, McLaughlin-Rotman Centre for Global Health. Canada Research Chair in Molecular Parasitology.
EN 13 - Room 214
Toronto General Hospital
200 Elizabeth Street
Toronto, Ontario, M5G 2C4
McLaughlin Centre for Molecular Medicine - MaRS Centre, TMDT
101 College Street
8th Floor, Suite 701
Toronto, Ontario M5G 1L7
Dr. Kain is a Professor of Medicine, University of Toronto, the Director of the McLaughlin-Rotman Centre for Global Health, holds a Canada Research Chair in Molecular Parasitology, and is the Director of The Center for Travel and Tropical Medicine at The Toronto General Hospital. Dr. Kain has worked extensively in the tropics and sub-tropics including New Guinea, Madagascar, Uganda, Laos, Thailand and the Amazon basin.
He is a Clinician-scientist at the University of Toronto and his research efforts focus on 1. Global Health; 2. malaria, including new diagnostics, drugs and vaccines for the prevention and treatment of malaria and the study of the molecular mechanisms underlying severe and cerebral malaria; and 3. diagnostics and surveillance of emerging infectious diseases associated with travel, migration and blood safety.
For More Articles by Dr. Kain Click Here
- Keen J, Farcas GA, Zhong K, Dunne MW, Kain KC
Real-time PCR assay for the rapid detection and analysis of PfCRT haplotypes of chloroquine-resistant Plasmodium falciparum isolates from India
J Clin Microbiol. Epub ahead of print, 7/3/2007.
- Cavalcanti RB, Raboud J, Shen S, Kain KC, Cheung A, Walmsley S
A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy
J Infect Dis. 195(12):1754-61, 6/15/2007.
- Hawkes M, Kain KC
Advances in malaria diagnosis.
Expert Rev Anti Infect Ther. 5(3):485-95, 6/1/2007.
- Keen J, Serghides L, Ayi K, Patel SN, Ayisi J, van Eijk A, Steketee R, Udhayakumar V, Kain KC
HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites
PLoS Med. 4(5):e181, 5/1/2007.
- Crockett M, Kain KC
Tafenoquine: a promising new antimalarial agent
Expert Opinion Drug 16(5):705-15, 5/1/2007.
- Patel SN, Lu Z, Ayi K, Serghides L, Gowda DC, Kain KC
Disruption of CD36 impairs cytokine response to Plasmodium falciparum glycosylphosphatidylinositol and confers susceptibility to severe and fatal malaria in vivo
J Immunol. 178(6):3954-61, 3/15/2007.
- Bello AM, Poduch E, Fujihashi M, Amani M, Li Y, Crandall I, Hui R, Lee PI, Kain KC, Pai EF, Kotra LP
A potent, covalent inhibitor of orotidine 5-monophosphate decarboxylase with antimalarial activity
J Med Microbiol. 50(5):915-21, 3/8/2007.
- Serghides L, Patel SN, Ayi K, Kain KC.
Placental chondroitin sulfate a-binding malarial isolates evade innate phagocytic clearance.
J Infect Dis. 194(1):133-9., 7/1/2006.
- Stauffer WM, Magill A, Kain KC.
Parasitic central nervous system infections in immunocompromised hosts: clarification of malaria diagnosis.
Clin Infect Dis. 43(1):114-5, 7/1/2006.
- Boggild AK, Yohanna S, Keystone JS, Kain KC.
Prospective analysis of parasitic infections in canadian travelers and immigrants.
J Travel Med 13(3):138-44., 6/1/2006.
This website has been made possible through an unrestricted educational grant from
Pfizer Canada Inc.